Aldeyra Therapeutics ALDX
NASDAQ ALDX
$1.18 -0.11 (-8.14%)
As of: Oct 2, 2026 · 3:08 PM EDT

Aldeyra Therapeutics (ALDX) Depreciation & Amortization (CF) (2014 - 2026)

Updated

Aldeyra Therapeutics' Depreciation & Amortization (CF) came in at $70,706 for Q2 2026, up 13.5% from $62,282 a year earlier and up 6.2% from the prior quarter.

Analysis

Aldeyra Therapeutics (ALDX) Depreciation & Amortization (CF) (2014 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Aldeyra Therapeutics reported Depreciation & Amortization (CF) of $266,104, up 6.2% year-over-year; for FY2025, it was $251,993, up 0.9% from FY2024.

  • Depreciation & Amortization (CF) carries a five-year compound annual growth rate of 35.0% (FY2020 to FY2025).
  • Going back by year, Depreciation & Amortization (CF) was $249,623 in FY2024 (-5.0%), $262,780 in FY2023 (+1.6%), $258,707 in FY2022 (-2.1%) and $264,180 in FY2021 (+369.9%).
  • The Q2 2026 figure represents the highest quarterly Depreciation & Amortization (CF) since Q3 2020.
  • Year-over-year, Depreciation & Amortization (CF) has increased for six consecutive quarters, with growth averaging 2.5% over the last eight quarters.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q2 2026 (growth of 13.5%), and the weakest in Q1 2024 (a decline of 9.5%).
  • Business Quant data shows ALDX's Depreciation & Amortization (CF) at $66,599 (Q1 2026), $65,116 (Q4 2025) and $63,683 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Aldeyra Therapeutics 74.19 Mn 74.19 Mn - 70,706.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 70,706.00
Mar 31, 2026 66,599.00
Dec 31, 2025 65,116.00
Sep 30, 2025 63,683.00
Jun 30, 2025 62,282.00
Mar 31, 2025 60,912.00
Dec 31, 2024 64,373.00
Sep 30, 2024 62,987.00
Jun 30, 2024 61,631.00
Mar 31, 2024 60,632.00
Dec 31, 2023 66,469.00
Sep 30, 2023 64,999.00
Jun 30, 2023 64,340.00
Mar 31, 2023 66,972.00
Dec 31, 2022 66,643.00
Sep 30, 2022 65,311.00
Jun 30, 2022 64,012.00
Mar 31, 2022 62,741.00
Dec 31, 2021 61,271.00
Sep 30, 2021 68,352.00
API Access

Aldeyra Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ALDX&period=max&api_key=YOUR_API_KEY